Hao Luo
Associate Scientific Director Bristol Myers Squibb
Hao Luo is an Associate Scientific Director at Bristol Myers Squibb within the Biologics Analytical Development and Attribute Sciences organization, where she leads the characterization and control strategy development for antibody conjugates. Her expertise encompasses a broad range of analytical methodologies, including charge variant analysis, impurity profiling, and advanced separation techniques.
Dr. Luo has contributed to multiple biologics programs supporting IND and regulatory submissions, with a focus on developing scientifically justified, phase-appropriate control strategies. Her work emphasizes a comprehensive understanding of critical quality attributes to ensure product quality, stability, and performance throughout development.
Seminars
- Understanding the sources and impacts of ADC charge variant profiles given impact from linker-payload properties
- Undergoing CQA assessments to determine ADC clinical relevance
- Defining compound-specific, phase-appropriate and value-focused control strategies
